Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.55 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.49 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.45 |
| ▸ | ABL1 | P00519 | 2/20 | 0.45 |
| ▸ | EGFR | P00533 | 2/20 | 0.45 |
| ▸ | HCK | P08631 | 2/20 | 0.45 |
| ▸ | SRC | P12931 | 2/20 | 0.45 |
| ▸ | KDR | P35968 | 2/20 | 0.45 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.45 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.45 |
| ▸ | MTOR | P42345 | 2/20 | 0.45 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.45 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.45 |
| ▸ | PRKDC | P78527 | 2/20 | 0.45 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.45 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.45 |
| ▸ | FABP4 | P15090 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30230816 | 1.00 | TUBB1 (0.55) | TUBB1TFPI2PIK3CDABL1EGFR | |
| SCHEMBL982760 | 0.89 | TFPI2 (0.49) | TUBB1TFPI2MTNR1AMTNR1BFABP4 | |
| SCHEMBL29992081 | 0.86 | PIK3CD (0.44) | TUBB1TFPI2PIK3CDABL1EGFR | |
| SCHEMBL1372514 | 0.86 | ELANE (0.47) | TUBB1TFPI2PIK3CDABL1EGFR | |
| SCHEMBL17061440 | 0.86 | PIK3CD (0.44) | TUBB1TFPI2PIK3CDABL1EGFR | |
| SCHEMBL3839289 | 0.86 | TFPI2 (0.51) | TUBB1TFPI2PIK3CDABL1EGFR | |
| SCHEMBL13247869 | 0.86 | PIK3CG (0.47) | TUBB1PIK3CDABL1EGFRHCK | |
| SCHEMBL7988808 | 0.85 | TUBB1 (0.60) | TUBB1TFPI2MTNR1AMTNR1BFABP4 | |
| SCHEMBL2720556 | 0.85 | KCNQ3 (0.47) | TUBB1TFPI2PIK3CDABL1EGFR | |
| SCHEMBL28683537 | 0.84 | TUBB1 (0.59) | TUBB1TFPI2MTNR1AMTNR1BFABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115398219-B | Capillary gel electrophoresis and its use in complex biomolecules | 阿瑞斯贸易股份公司 | 2025-04-01 | — | — | CN | disclosed |
| US-20240254081-A1 | CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2024-08-01 | — | — | US | disclosed |
| EP-4133263-B1 | CAPILLARY GEL ELECTROPHORESIS AND ITS USE WITH COMPLEX BIOLOGICAL MOLECULES | ARES TRADING SA (CH) | 2024-05-22 | — | — | EP | disclosed |
| EP-4334285-A1 | CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS | Kare Chemical Technologies Inc. (CA) | 2024-03-13 | — | — | EP | disclosed |
| CN-117597329-A | Method for the catalytic synthesis of tryptamine and precursors thereof | 凯尔化学科技公司 | 2024-02-23 | — | — | CN | disclosed |
| US-11664093-B2 | Extrapolative prediction of enantioselectivity enabled by computer-driven workflow, new molecular representations and machine learning | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-05-30 | — | — | US | disclosed |
| US-20230152275-A1 | CAPILLARY GEL ELECTROPHORESIS AND ITS USE WITH COMPLEX BIOLOGICAL MOLECULES | ARES TRADING S.A. (CH) | 2023-05-18 | — | — | US | disclosed |
| EP-4133263-A1 | CAPILLARY GEL ELECTROPHORESIS AND ITS USE WITH COMPLEX BIOLOGICAL MOLECULES | Ares Trading S.A. (CH) | 2023-02-15 | — | — | EP | disclosed |
| CN-115398219-A | Capillary gel electrophoresis and its use in complex biomolecules | 阿瑞斯贸易股份公司 | 2022-11-25 | — | — | CN | disclosed |
| WO-2022232931-A1 | CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2022-11-10 | — | — | WO | disclosed |
| WO-2011092293-A2 | CYCLOHEXYL AMIDE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS | NOVARTIS AG (CH) | 2011-08-04 | — | — | WO | disclosed |
| US-20100144726-A1 | NOVEL INDOLIC DERIVATIVES, THEIR PREPARATION PROCESSES AND THEIR USES IN PARTICULAR AS ANTIBACTERIALS | UNIVERSITE JOSEPH FOURIER (FR) | 2010-06-10 | — | — | US | disclosed |
| EP-1276720-B1 | 2-ACYL INDOL DERIVATIVES AND THEIR USE AS ANTI-TUMOUR AGENTS | BAXTER HEALTHCARE SA (CH) | 2006-12-20 | — | — | EP | disclosed |
| EP-1442015-A1 | USE OF 2-ACYLINDOLES IN THE TREATMENT OF TUMORS | Baxter Healthcare SA (CH) | 2004-08-04 | — | — | EP | disclosed |
| US-20030158216-A1 | 2-acyl indole derivatives and their use as antitumor agents | BAXTER ONCOLOGY GMBH | 2003-08-21 | — | — | US | disclosed |
| WO-2003037861-A1 | USE OF 2-ACYLINDOLES IN THE TREATMENT OF TUMORS | BAXTER HEALTHCARE SA (CH) | 2003-05-08 | — | — | WO | disclosed |
| EP-1276720-A2 | 2-ACYL INDOL DERIVATIVES AND THEIR USE AS ANTI-TUMOUR AGENTS | ASTA Medica AG (DE) | 2003-01-22 | — | — | EP | disclosed |
| US-20020091124-A1 | 2-acyl indole derivatives and their use as antitumor agents | BECKERS THOMAS (DE) | 2002-07-11 | — | — | US | disclosed |
| CN-1331674-A | Sulfonamide hydroxamates | HOFFMANN LA ROCHE (CH) | 2002-01-16 | — | — | CN | disclosed |
| WO-2001082909-A2 | 2-ACYL INDOL DERIVATIVES AND THEIR USE AS ANTI-TUMOUR AGENTS | BAXTER HEALTHCARE SA (DE) | 2001-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254081-A1 | CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS | HNMT, TPSB2, TPSG1 | TUBB1 2205/4885TFPI2 555/4885PIK3CD 3971/4885 |
| US-20030158216-A1 | 2-acyl indole derivatives and their use as antitumor agents | IDO1, IDO2, INMT | TUBB1 62/4885TFPI2 363/4885PIK3CD 1422/4885 |
| US-20020091124-A1 | 2-acyl indole derivatives and their use as antitumor agents | IDO1, IDO2, INMT | TUBB1 62/4885TFPI2 363/4885PIK3CD 1422/4885 |
| US-20100144726-A1 | NOVEL INDOLIC DERIVATIVES, THEIR PREPARATION PROCESSES AND THEIR USES IN PARTICULAR AS ANTIBACTERIALS | GPBAR1, TPH1, GPER1 | TUBB1 1252/4885TFPI2 3450/4885PIK3CD 3789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.